000 01430 a2200349 4500
005 20250518045158.0
264 0 _c20200921
008 202009s 0 0 eng d
022 _a1827-1758
024 7 _a10.23736/S0393-2249.19.03408-8
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSun, Yi
245 0 0 _aStudy of phosphodiesterase 5 inhibitors and α-adrenoceptor antagonists used alone or in combination for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
_h[electronic resource]
260 _bMinerva urologica e nefrologica = The Italian journal of urology and nephrology
_cFeb 2020
300 _a13-21 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenergic alpha-Antagonists
_xadverse effects
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLower Urinary Tract Symptoms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPhosphodiesterase 5 Inhibitors
_xadverse effects
650 0 4 _aProstatic Hyperplasia
_xdrug therapy
650 0 4 _aQuality of Life
700 1 _aPeng, Bo
700 1 _aLei, Guo-Lin
700 1 _aWei, Qiang
700 1 _aYang, Lu
773 0 _tMinerva urologica e nefrologica = The Italian journal of urology and nephrology
_gvol. 72
_gno. 1
_gp. 13-21
856 4 0 _uhttps://doi.org/10.23736/S0393-2249.19.03408-8
_zAvailable from publisher's website
999 _c29837958
_d29837958